The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.

Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.

Crops produced using mutagenic technologies such as CRISPR should generally be exempt from regulatory laws governing GMOs, according to the published opinion.

The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.

After resigning from the University of New England last year, Geoffrey Bove continues to study the effects of massage on rats in a facility he set up in his house.

"If centuries are to be burdened with names, our own may bear the title of the century of science," write David Collingridge and Colin Reeve in their book Science Speaks to Power: The Role of Experts in Policymaking (Frances Pinter Publishers Ltd., 1986). As science and technology become increasingly important in issues of broad social import, how can science best inform the policymaking process? Historians and sociologists of science debate the merits of new agencies like the Science Policy Sup

Many preclinical studies carried out in vivo are poorly designed and generate irreproducible data, but efforts to address the problem are on the rise.

Becoming a neuroscientist with a service dog by your side presents numerous challenges. Joey Ramp, who went back to college to study her own post-traumatic stress disorder, is learning this the hard way.

Joey Ramp went back to college to study post-traumatic stress disorder. But the dogs that help her manage her own PTSD complicate her research career.

David T Kingsbury, assistant director for biological, behavioral and social sciences at the National Science Foundation, has been described as the Reagan administration's point man on biotechnology. As chairman of the Biotechnology Science Coordinating Committee formed under the White House Office of Science and Technology Policy, Kingsbury was the principal architect of the Coordinated Framework for Biotechnology, which President Reagan signed last June. After receiving his Ph.D. in 1971, Kings